LUSSO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 15.681
NA - Nord America 4.698
AS - Asia 1.714
SA - Sud America 225
AF - Africa 29
OC - Oceania 4
Totale 22.351
Nazione #
IT - Italia 14.671
US - Stati Uniti d'America 4.655
SG - Singapore 669
CN - Cina 645
UA - Ucraina 352
SE - Svezia 224
BR - Brasile 175
FI - Finlandia 123
VN - Vietnam 119
DE - Germania 98
GB - Regno Unito 89
FR - Francia 78
IN - India 60
BD - Bangladesh 50
HK - Hong Kong 42
KR - Corea 39
RU - Federazione Russa 22
CA - Canada 20
TR - Turchia 17
AR - Argentina 16
IQ - Iraq 12
MX - Messico 11
CO - Colombia 9
ID - Indonesia 9
EC - Ecuador 8
UZ - Uzbekistan 8
PH - Filippine 7
PK - Pakistan 7
NL - Olanda 6
PY - Paraguay 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
ES - Italia 4
JM - Giamaica 4
KE - Kenya 4
MA - Marocco 4
MU - Mauritius 4
VE - Venezuela 4
AU - Australia 3
CL - Cile 3
ET - Etiopia 3
JP - Giappone 3
MY - Malesia 3
NP - Nepal 3
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
IE - Irlanda 2
IL - Israele 2
KZ - Kazakistan 2
LT - Lituania 2
PL - Polonia 2
TN - Tunisia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 22.351
Città #
Cagliari 14.341
Woodbridge 538
Fairfield 534
Singapore 360
Houston 344
Ashburn 322
Chandler 315
Seattle 243
Ann Arbor 224
San Jose 218
Cambridge 203
Wilmington 196
Boardman 193
Jacksonville 189
Dallas 163
Nyköping 153
Uta 143
Beijing 132
Los Angeles 84
Hefei 76
Santa Clara 69
Helsinki 64
Boston 56
Buffalo 56
Nanjing 51
Council Bluffs 45
Lauterbourg 45
San Diego 43
Hong Kong 39
Seoul 36
Shanghai 34
Ho Chi Minh City 32
Milan 32
Verona 29
Pune 27
The Dalles 25
Nanchang 23
Hanoi 22
Hebei 22
Jiaxing 20
New York 19
Changsha 18
Jinan 17
Shenyang 16
Munich 15
Tianjin 15
Sassari 14
Frankfurt am Main 12
Guangzhou 11
London 10
São Paulo 10
Haiphong 9
Belo Horizonte 8
Chicago 8
Norwalk 8
Nuremberg 7
Tashkent 7
Zhengzhou 7
Brooklyn 6
Delhi 6
Denver 6
Mountain View 6
Ningbo 6
Orange 6
Washington 6
Atlanta 5
Baghdad 5
Can Tho 5
Dhaka 5
Saint Petersburg 5
San Francisco 5
Columbus 4
Goiânia 4
Hangzhou 4
Kingston 4
Montreal 4
Redwood City 4
Salt Lake City 4
Taizhou 4
Toronto 4
Asunción 3
Bangalore 3
Biên Hòa 3
Curitiba 3
Da Nang 3
Dearborn 3
Düsseldorf 3
Erbil 3
Hamburg 3
Johannesburg 3
Kunming 3
Mississauga 3
Nairobi 3
Orem 3
Paris 3
Phoenix 3
Porto Alegre 3
Portsmouth 3
Queens 3
Rio de Janeiro 3
Totale 20.120
Nome #
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 1.695
Calibration Technologies for Correct Determination of Epstein-Barr Virus, Human Herpesvirus 6 (HHV-6), and HHV-8 Antiviral Drug Susceptibilities by Use of Real-Time-PCR-Based Assays 609
Chromosomally integrated human herpesvirus 6: questions and answers 585
Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity 579
Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor 579
Enhancement of Anti-HIV-1 Activity by Hot Spot Evolution of RANTES-Derived Peptides 567
Glycosylation, Hypogammaglobulinemia, and Resistance to Viral Infections 566
Development of a Human Herpesvirus 6 Species-Specific Immunoblotting Assay 555
Classification of HHV-6A and HHV-6B as distinct viruses 550
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses 547
Selective Reactivation of Human Herpesvirus 6 in Patients With Autoimmune Connective Tissue Diseases 538
Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples 515
The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1 503
Treatment with IL-7 Prevents the Decline of Circulating CD4(+) T Cells during the Acute Phase of SIV Infection in Rhesus Macaques 494
HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis 486
Protein-based HIV-1 microbicides. 483
Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability 483
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4(pos) T cells and macrophages 482
lmmunomodulation and immunosuppression by human herpesvirus 6A and 6B 475
IL-7 induces expression and activation of integrin alpha 4 beta 7 promoting naive T-cell homing to the intestinal mucosa 427
Inhibition of HIV-1 Infection by Human alpha-Defensin-5, a Natural Antimicrobial Peptide Expressed in the Genital and Intestinal Mucosae 424
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants 391
Human herpesvirus 6A accelerates AIDS progression in macaques 361
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT 349
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A 343
Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases 332
Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages 329
Clinical significance of HIV-1 coreceptor usage 328
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity 326
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein 325
A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load 319
International network for comparison of HIV neutralization assays: the NeutNet report 318
A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2 317
Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection 316
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers 314
Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer 311
Rational design of novel HIV-1 entry inhibitors by RANTES engineering 307
Broad-Spectrum Inhibition of HIV-1 by a Monoclonal Antibody Directed against a gp120-Induced Epitope of CD4 307
Identification of RANTES MIP-1 alpha and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells 296
HHV-6 and CMV pneumonitis in immunocompromised patients 283
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains 281
Infection of natural killer cells by human herpesvirus 6 265
Selective suppression of IL-12 production by human herpesvirus 6 261
CD46 is a cellular receptor for human herpesvirus 6 256
: Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4 256
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 256
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals 252
Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection 251
HHV-6 and the immune system: mechanisms of immunomodulation and viral escape 250
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression 243
HIV and the chemokine system 243
Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation 242
A rationally designed CD4 mimic inhibits HIV-1 entry and exposes cryptic neutralization epitopes 227
Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6 221
HIV and chemokines: Implications for therapy and vaccines 198
Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity 192
Structural determinants of HIV-1 blockade and CCR5 recognition in RANTES 189
Totale 22.397
Categoria #
all - tutte 45.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.489


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 0 0 0 0 0 0 70
2021/2022652 49 121 39 19 36 15 44 29 64 42 94 100
2022/20231.191 130 115 112 97 101 175 46 127 126 37 55 70
2023/20241.601 120 47 72 172 143 143 86 110 82 329 131 166
2024/20251.476 101 101 243 93 160 129 88 60 125 95 131 150
2025/20262.068 148 135 342 148 147 183 320 69 158 203 178 37
Totale 22.397